Clinical Trials 2018-01-15T20:14:10+00:00

Clinical research

Clinical trials are designed to evaluate the safety and effectiveness of new drugs, devices, or behavioural therapies. Clinical trials are also referred to as clinical studies or clinical programs.

What you need to know:

  • Your participation in any clinical program is voluntary; you may stop participation at any time
  • All personal information collected is confidential
  • Before you participate in any study you will be given information about the study, its risks and benefits; your questions will be answered
  • You will have as much time as you need to decide if you are interested to participate
  • Consent form is an important document that outlines the information about the clinical program including all procedures, potential risks and benefits, information about protecting your privacy, other procedures or treatments to consider, and who to contact with questions

Clinical trials done in Canada are regulated by Health Canada. Clinical trials database can be found at https://health-products.canada.ca/ctdb-bdec/index-eng.jspis

Areas of research

  • Psoriasis
  • Hidradenitis suppurativa
  • Dermatitis / eczema
  • Actinic keratoses

Psoriasis

  • Complete-PS:Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriasis (CLOSED)
  • PURE: A registry of Patients with moderate to severe chronic plaque psoriasis in Canada and Latin AmErica (LACan)
  • LEO 90100 twice weekly maintenance regimen for psoriasis vulgaris. Phase 3 trial comparing the efficacy and safety of LEO 90100 aerosol foam with the aerosol foam vehicle used twice weekly as long term maintenance therapy in patients with psoriasis vulgaris.
  • See more about Psoriasis

Palmo-plantar pustulosis

  • Multi-center, double-blind, randomized, placebo-controlled, phase IIa study to investigate efficacy, safety, tolerability, pharmacokinetics and pharmacogenomics of multiple intravenous doses of BI 655130 in patients with Palmoplantar Pustulosis (PPP)

Hidradenitis suppurativa

  • SOLACE – P15-696: Canadian Humira PoSt Marketing Observational EpidemiologicaL Study: Assessing Humira Real Life EffeCtiveness and Impact on ModeratE to Severe Hidradenitis Suppurativa (HS) Burden of Illness and Health Care Resources Utilization

Dermatitis/ eczema

  • ECZTRA -1. A Muticenter, Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety od Tralokinumab in Patients with Atopic Dermatitis Inadequately controlled on Topical Corticosteroid therapy
  • DS 107E-06 A randomized, double blind, vehicle controlled, phase IIb study to assess the efficacy and safety of topically applied DS 107 Cream in adults with mild to moderate atopic dermatitis
  • See more about Dermatitis

Actinic keratosis

  • The RAPID-ACT Study: The Real Life Topical Field Treatment of Actinic Keratosis Study. An Observation study focusing on Patient Reported Outcomes (CLOSED)
  • Efficacy and Safety of Ingenol Mebutate Gel in Field Treatment of Actinic Keratosis on Full Face, Balding Scalp or Approximately 250 cm2 on the Chest (CLOSED)
  • Efficacy and Safety of Leo 43204 in Field Treatment of Actinic Keratosis on Face or Chest including 12-month follow up (CLOSED)

 

Contact us:

Shannon Bolduc  – Clinical trials coordinator
Phone: 506 459-1808
Email: Clinicaltrials.bdc@gmail.com

or fill out this online form

Your Name (required)

Your Email (required)

Conditions:
PsoriasisHidradenitis suppurativaDermatitis / eczemaActinic keratosesOther

Additional Information